Added to YB: 2025-08-27
Pitch date: 2025-08-25
BANB.SW [bullish]
Bachem Holding AG
-19.22%
current return
Author Info
No bio for this author
Company Info
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
Market Cap
CHF 5.1B
Pitch Price
CHF 65.80
Price Target
90.00 (+69%)
Dividend
1.25%
EV/EBITDA
25.61
P/E
37.74
EV/Sales
7.54
Sector
Life Sciences Tools and Services
Category
growth
BANB.SW Raised Guidance, Targets >CHF 1B Sales by 2026
BANB.SW: Swiss peptide leader riding GLP-1 boom. H1'25 sales +30% YoY to CHF313M, EBITDA +64% (29.1% margin). Targeting >CHF1B sales by 2026 w/ >30% margins (vs CHF605M in 2024). New Building K plant key catalyst 2H'25. Trading 28.7x EV/EBITDA, de-rates to 14-17x on 2026 plan execution. PT CHF90 vs CHF66.5.
Read full article (2 min)